These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 20359848)

  • 41. Bone morphogenetic proteins signal through the transforming growth factor-beta type III receptor.
    Kirkbride KC; Townsend TA; Bruinsma MW; Barnett JV; Blobe GC
    J Biol Chem; 2008 Mar; 283(12):7628-37. PubMed ID: 18184661
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Knockdown of electron transfer flavoprotein β subunit reduced TGF-β-induced α-SMA mRNA expression but not COL1A1 in fibroblast-populated three-dimensional collagen gel cultures.
    Hirokawa S; Shimanuki T; Kitajima H; Nishimori Y; Shimosaka M
    J Dermatol Sci; 2012 Dec; 68(3):179-86. PubMed ID: 23068445
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transforming growth factor-beta blocks inhibin binding to different target cell types in a context-dependent manner through dual mechanisms involving betaglycan.
    Farnworth PG; Wang Y; Escalona R; Leembruggen P; Ooi GT; Findlay JK
    Endocrinology; 2007 Nov; 148(11):5355-68. PubMed ID: 17656464
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transforming growth factor-beta (TGF-beta) type I and type II receptors are both required for TGF-beta-mediated extracellular matrix production in lung fibroblasts.
    Zhao Y
    Mol Cell Endocrinol; 1999 Apr; 150(1-2):91-7. PubMed ID: 10411303
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TGFBR3, a potential negative regulator of TGF-β signaling, protects cardiac fibroblasts from hypoxia-induced apoptosis.
    Chu W; Li X; Li C; Wan L; Shi H; Song X; Liu X; Chen X; Zhang C; Shan H; Lu Y; Yang B
    J Cell Physiol; 2011 Oct; 226(10):2586-94. PubMed ID: 21792916
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of TGF-β/Smad signaling by BAMBI blocks differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and abolishes their protumor effects.
    Shangguan L; Ti X; Krause U; Hai B; Zhao Y; Yang Z; Liu F
    Stem Cells; 2012 Dec; 30(12):2810-9. PubMed ID: 23034983
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intracellular TGF-beta receptor blockade abrogates Smad-dependent fibroblast activation in vitro and in vivo.
    Ishida W; Mori Y; Lakos G; Sun L; Shan F; Bowes S; Josiah S; Lee WC; Singh J; Ling LE; Varga J
    J Invest Dermatol; 2006 Aug; 126(8):1733-44. PubMed ID: 16741519
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts.
    Cipriani P; Di Benedetto P; Ruscitti P; Verzella D; Fischietti M; Zazzeroni F; Liakouli V; Carubbi F; Berardicurti O; Alesse E; Giacomelli R
    Arthritis Res Ther; 2015 Sep; 17(1):247. PubMed ID: 26357964
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A tumor-promoting role for soluble TβRIII in glioblastoma.
    Burghardt I; Schroeder JJ; Weiss T; Gramatzki D; Weller M
    Mol Cell Biochem; 2021 Aug; 476(8):2963-2973. PubMed ID: 33772427
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of soluble transforming growth factor-beta receptor III (sTbetaIII) in rat milk.
    Zhang M; Zola H; Read L; Penttila I
    Immunol Cell Biol; 2001 Jun; 79(3):291-7. PubMed ID: 11380683
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tensin 1 Is Essential for Myofibroblast Differentiation and Extracellular Matrix Formation.
    Bernau K; Torr EE; Evans MD; Aoki JK; Ngam CR; Sandbo N
    Am J Respir Cell Mol Biol; 2017 Apr; 56(4):465-476. PubMed ID: 28005397
    [TBL] [Abstract][Full Text] [Related]  

  • 52. βarrestin2 interacts with TβRII to regulate Smad-dependent and Smad-independent signal transduction.
    McLean S; Bhattacharya M; Di Guglielmo GM
    Cell Signal; 2013 Jan; 25(1):319-31. PubMed ID: 23069267
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of transforming growth factor-β via the activin receptor-like kinase-5 inhibitor attenuates pulmonary fibrosis.
    Koh RY; Lim CL; Uhal BD; Abdullah M; Vidyadaran S; Ho CC; Seow HF
    Mol Med Rep; 2015 May; 11(5):3808-13. PubMed ID: 25585520
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antifibrotic effects of focal adhesion kinase inhibitor in bleomycin-induced pulmonary fibrosis in mice.
    Kinoshita K; Aono Y; Azuma M; Kishi J; Takezaki A; Kishi M; Makino H; Okazaki H; Uehara H; Izumi K; Sone S; Nishioka Y
    Am J Respir Cell Mol Biol; 2013 Oct; 49(4):536-43. PubMed ID: 23642017
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ALK1 regulates the internalization of endoglin and the type III TGF-β receptor.
    Tazat K; Pomeraniec-Abudy L; Hector-Greene M; Szilágyi SS; Sharma S; Cai EM; Corona AL; Ehrlich M; Blobe GC; Henis YI
    Mol Biol Cell; 2021 Apr; 32(7):605-621. PubMed ID: 33566682
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Towards predicting the lung fibrogenic activity of MWCNT: Key role of endocytosis, kinase receptors and ERK 1/2 signaling.
    Vietti G; Ibouraadaten S; Palmai-Pallag M; Yakoub Y; Piret JP; Marbaix E; Lison D; van den Brule S
    Nanotoxicology; 2016; 10(4):488-500. PubMed ID: 26444902
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Novel mTOR Complex 1/2 Inhibitor P529 Inhibits Human Lung Myofibroblast Differentiation.
    Ferguson KT; Torr EE; Bernau K; Leet J; Sherris D; Sandbo N
    J Cell Biochem; 2017 Aug; 118(8):2241-2249. PubMed ID: 28078713
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The hedgehog system machinery controls transforming growth factor-β-dependent myofibroblastic differentiation in humans: involvement in idiopathic pulmonary fibrosis.
    Cigna N; Farrokhi Moshai E; Brayer S; Marchal-Somme J; Wémeau-Stervinou L; Fabre A; Mal H; Lesèche G; Dehoux M; Soler P; Crestani B; Mailleux AA
    Am J Pathol; 2012 Dec; 181(6):2126-37. PubMed ID: 23031257
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prostaglandin E2 increases transforming growth factor-beta type III receptor expression through CCAAT enhancer-binding protein delta in osteoblasts.
    McCarthy TL; Pham TH; Knoll BI; Centrella M
    Mol Endocrinol; 2007 Nov; 21(11):2713-24. PubMed ID: 17636036
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Decreased expression of the type III TGF-β receptor enhances metastasis and invasion in hepatocellullar carcinoma progression.
    Zhang S; Sun WY; Wu JJ; Gu YJ; Wei W
    Oncol Rep; 2016 Apr; 35(4):2373-81. PubMed ID: 26882862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.